On Robustness of Massive MIMO Systems Against Passive Eavesdropping under Antenna Selection

In massive MIMO wiretap settings, the base station can significantly suppress eavesdroppers by narrow beamforming toward legitimate terminals. Numerical investigations show that by this approach, secrecy is obtained at no significant cost. We call this property of massive MIMO systems `secrecy for free' and show that it not only holds when all the transmit antennas at the base station are employed, but also when only a single antenna is set active. Using linear precoding, the information leakage to the eavesdroppers can be sufficiently diminished, when the total number of available transmit antennas at the base station grows large, even when only a fixed number of them are selected. This result indicates that passive eavesdropping has no significant impact on massive MIMO systems, regardless of the number of active transmit antennas.Comment: 7 pages, 2 figures; To be presented in IEEE Global Communications Conference (Globecom) 2018 in Abu Dhabi, UA

Optimal Number of Transmit Antennas for Secrecy Enhancement in Massive MIMOME Channels

This paper studies the impact of transmit antenna selection on the secrecy performance of massive MIMO wiretap channels. We consider a scenario in which a multi-antenna transmitter selects a subset of transmit antennas with the strongest channel gains. Confidential messages are then transmitted to a multi-antenna legitimate receiver while the channel is being overheard by a multi-antenna eavesdropper. For this setup, we approximate the distribution of the instantaneous secrecy rate in the large-system limit. The approximation enables us to investigate the optimal number of selected antennas which maximizes the asymptotic secrecy throughput of the system. We show that increasing the number of selected antennas enhances the secrecy performance of the system up to some optimal value, and that further growth in the number of selected antennas has a destructive effect. Using the large-system approximation, we obtain the optimal number of selected antennas analytically for various scenarios. Our numerical investigations show an accurate match between simulations and the analytic results even for not so large dimensions.Comment: 6 pages, 4 figures, IEEE GLOBECOM 201

Breast Cancer MRI Classification Based on Fractional Entropy Image Enhancement and Deep Feature Extraction

سرطان الثدي يعتبر واحد من الامراض القاتلة الشائعة بين النساء في جميع أنحاء العالم. والتشخيص المبكر لسرطان الثدي الكشف المبكر من أهم استراتيجيات الوقاية الثانوية. نظرًا لاستخدام التصوير الطبي على نطاق واسع في تشخيص العديد من الأمراض المزمنة ومراقبتها، فقد تم اقتراح العديد من خوارزميات معالجة الصور على مر السنين لزيادة مجال التصوير الطبي بحيث تصبح عملية التشخيص أكثر دقة وكفاءة. تقدم هذه الدراسة خوارزمية جديدة لاستخراج الخواص العميقة من نوعين من صور الرنين المغناطيسي T2W-TSE و STIR MRI كمدخلات للشبكات العصبية العميقة المقترحة والتي تُستخدم لاستخراج الخواص للتمييز بين فحوصات التصوير بالرنين المغناطيسي للثدي المرضية والصحية. في هذه الخوارزمية، تتم معالجة فحوصات التصوير بالرنين المغناطيسي للثدي مسبقًا قبل خطوة استخراج الخواص لتقليل تأثيرات الاختلافات بين شرائح التصوير بالرنين المغناطيسي، وفصل الثدي الايمن عن الايسر، بالإضافة الى عزل خلفية الصور. وقد كانت أقصى دقة تم تحقيقها لتصنيف مجموعة بيانات تضم 326 شريحة تصوير بالرنين المغناطيسي للثدي 98.77٪. يبدو أن النموذج يتسم بالكفاءة والأداء ويمكن بالتالي اعتباره مرشحًا للتطبيق في بيئة سريرية.Disease diagnosis with computer-aided methods has been extensively studied and applied in diagnosing and monitoring of several chronic diseases. Early detection and risk assessment of breast diseases based on clinical data is helpful for doctors to make early diagnosis and monitor the disease progression. The purpose of this study is to exploit the Convolutional Neural Network (CNN) in discriminating breast MRI scans into pathological and healthy. In this study, a fully automated and efficient deep features extraction algorithm that exploits the spatial information obtained from both T2W-TSE and STIR MRI sequences to discriminate between pathological and healthy breast MRI scans. The breast MRI scans are preprocessed prior to the feature extraction step to enhance and preserve the fine details of the breast MRI scans boundaries by using fractional integral entropy FIE algorithm, to reduce the effects of the intensity variations between MRI slices, and finally to separate the right and left breast regions by exploiting the symmetry information. The obtained features are classified using a long short-term memory (LSTM) neural network classifier. Subsequently, all extracted features significantly improves the performance of the LSTM network to precisely discriminate between pathological and healthy cases. The maximum achieved accuracy for classifying the collected dataset comprising 326 T2W-TSE images and 326 STIR images is 98.77%. The experimental results demonstrate that FIE enhancement method improve the performance of CNN in classifying breast MRI scans. The proposed model appears to be efficient and might represent a useful diagnostic tool in the evaluation of MRI breast scans

Demystifying Smoker's Paradox: A Propensity Score-Weighted Analysis in Patients Hospitalized With Acute Heart Failure.

Background Smoker's paradox has been observed with several vascular disorders, yet there are limited data in patients with acute heart failure (HF). We examined the effects of smoking in patients with acute HF using data from a large multicenter registry. The objective was to determine if the design and analytic approach could explain the smoker's paradox in acute HF mortality. Methods and Results The data were sourced from the acute HF registry (Gulf CARE [Gulf Acute Heart Failure Registry]), a multicenter registry that recruited patients over 10 months admitted with a diagnosis of acute HF from 47 hospitals in 7 Middle Eastern countries. The association between smoking and mortality (in hospital) was examined using covariate adjustment, making use of mortality risk factors. A parallel analysis was performed using covariate balancing through propensity scores. Of 5005 patients hospitalized with acute HF, 1103 (22%) were current smokers. The in-hospital mortality rates were significantly lower in current smoker's before (odds ratio, 0.71; 95% CI, 0.52-0.96) and more so after (odds ratio, 0.47; 95% CI, 0.31-0.70) covariate adjustment. With the propensity score-derived covariate balance, the smoking effect became much less certain (odds ratio, 0.63; 95% CI, 0.36-1.11). Conclusions The current study illustrates the fact that the smoker's paradox is likely to be a result of residual confounding as covariate adjustment may not resolve this if there are many competing prognostic confounders. In this situation, propensity score methods for covariate balancing seem preferable. Clinical Trial Registration URL: https://www.clinicaltrials.gov/. Unique identifier: NCT01467973.Gulf CARE (Gulf Acute Heart Failure Registry) is an investigator- initiated study conducted under the auspices of the Gulf Heart Association and funded by Servier, Paris, France; and (for centers in Saudi Arabia), by the Saudi Heart Association (The Deanship of Scientific Research at King Saud University, Riyadh, Saudi Arabia [research group number: RG -1436- 013]). This does not alter our adherence to policies on sharing data and materials; and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The publication of this article was funded by the Qatar National Library

Generalized Bose-Einstein Condensation

Generalized Bose-Einstein condensation (GBEC) involves condensates appearing simultaneously in multiple states. We review examples of the three types in an ideal Bose gas with different geometries. In Type I there is a discrete number of quantum states each having macroscopic occupation; Type II has condensation into a continuous band of states, with each state having macroscopic occupation; in Type III each state is microscopically occupied while the entire condensate band is macroscopically occupied. We begin by discussing Type I or "normal" BEC into a single state for an isotropic harmonic oscillator potential. Other geometries and external potentials are then considered: the {}"channel" potential (harmonic in one dimension and hard-wall in the other), which displays Type II, the {}"cigar trap" (anisotropic harmonic potential), and the "Casimir prism" (an elongated box), the latter two having Type III condensations. General box geometries are considered in an appendix. We particularly focus on the cigar trap, which Van Druten and Ketterle first showed had a two-step condensation: a GBEC into a band of states at a temperature $T_{c}$ and another "one-dimensional" transition at a lower temperature $T_{1}$ into the ground state. In a thermodynamic limit in which the ratio of the dimensions of the anisotropic harmonic trap is kept fixed, $T_{1}$ merges with the upper transition, which then becomes a normal BEC. However, in the thermodynamic limit of Beau and Zagrebnov, in which the ratio of the boundary lengths increases exponentially, $T_{1}$ becomes fixed at the temperature of a true Type I phase transition. The effects of interactions on GBEC are discussed and we show that there is evidence that Type III condensation may have been observed in the cigar trap.Comment: 17 pages; 6 figures. Intended for American Journal of Physic

Clinical presentation and outcomes of peripartum cardiomyopathy in the Middle East: a cohort from seven Arab countries

Aims: Published data on the clinical presentation of peripartum cardiomyopathy (PPCM) are very limited particularly from the Middle East. The aim of this study was to examine the clinical presentation, management, and outcomes of patients with PPCM using data from a large multicentre heart failure (HF) registry from the Middle East. Methods and results: From February to November 2012, a total of 5005 consecutive patients with HF were enrolled from 47 hospitals in 7 Middle East countries. From this cohort, patients with PPCM were identified and included in this study. Clinical features, in-hospital, and 12 months outcomes were examined. During the study period, 64 patients with PPCM were enrolled with a mean age of 32.5 ± 5.8 years. Family history was identified in 11 patients (17.2%) and hypertension in 7 patients (10.9%). The predominant presenting symptom was dyspnoea New York Heart Association class IV in 51.6%, class III in 31.3%, and class II in 17.2%. Basal lung crepitations and peripheral oedema were the predominant signs on clinical examination (98.2% and 84.4%, respectively). Most patients received evidence-based HF therapies. Inotropic support and mechanical ventilation were required in 16% and 5% of patients, respectively. There was one in-hospital death (1.6%), and after 1 year of follow-up, nine patients were rehospitalized with HF (15%), and one patient died (1.6%). Conclusions: A high index of suspicion of PPCM is required to make the diagnosis especially in the presence of family history of HF or cardiomyopathy. Further studies are warranted on the genetic basis of PPCM.Gulf CARE is an investigator-initiated study conducted under the auspices of the Gulf Heart Association and funded by Servier, Paris, France, and (for centres in Saudi Arabia) by the Saudi Heart Association [The Deanship of Scientific Research at King Saud University, Riyadh, Saudi Arabia (Research Group Number RG-1436-013)]. This does not alter our adherence to policies on sharing data and materials, and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript

Small airways obstruction and its risk factors in the Burden of Obstructive Lung Disease (BOLD) study: a multinational cross-sectional study

© 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.Background: Small airways obstruction is a common feature of obstructive lung diseases. Research is scarce on small airways obstruction, its global prevalence, and risk factors. We aimed to estimate the prevalence of small airways obstruction, examine the associated risk factors, and compare the findings for two different spirometry parameters. Methods: The Burden of Obstructive Lung Disease study is a multinational cross-sectional study of 41 municipalities in 34 countries across all WHO regions. Adults aged 40 years or older who were not living in an institution were eligible to participate. To ensure a representative sample, participants were selected from a random sample of the population according to a predefined site-specific sampling strategy. We included participants' data in this study if they completed the core study questionnaire and had acceptable spirometry according to predefined quality criteria. We excluded participants with a contraindication for lung function testing. We defined small airways obstruction as either mean forced expiratory flow rate between 25% and 75% of the forced vital capacity (FEF25-75) less than the lower limit of normal or forced expiratory volume in 3 s to forced vital capacity ratio (FEV3/FVC ratio) less than the lower limit of normal. We estimated the prevalence of pre-bronchodilator (ie, before administration of 200 μg salbutamol) and post-bronchodilator (ie, after administration of 200 μg salbutamol) small airways obstruction for each site. To identify risk factors for small airways obstruction, we performed multivariable regression analyses within each site and pooled estimates using random-effects meta-analysis. Findings: 36 618 participants were recruited between Jan 2, 2003, and Dec 26, 2016. Data were collected from participants at recruitment. Of the recruited participants, 28 604 participants had acceptable spirometry and completed the core study questionnaire. Data were available for 26 443 participants for FEV3/FVC ratio and 25 961 participants for FEF25-75. Of the 26 443 participants included, 12 490 were men and 13 953 were women. Prevalence of pre-bronchodilator small airways obstruction ranged from 5% (34 of 624 participants) in Tartu, Estonia, to 34% (189 of 555 participants) in Mysore, India, for FEF25-75, and for FEV3/FVC ratio it ranged from 5% (31 of 684) in Riyadh, Saudi Arabia, to 31% (287 of 924) in Salzburg, Austria. Prevalence of post-bronchodilator small airways obstruction was universally lower. Risk factors significantly associated with FEV3/FVC ratio less than the lower limit of normal included increasing age, low BMI, active and passive smoking, low level of education, working in a dusty job for more than 10 years, previous tuberculosis, and family history of chronic obstructive pulmonary disease. Results were similar for FEF25-75, except for increasing age, which was associated with reduced odds of small airways obstruction. Interpretation: Despite the wide geographical variation, small airways obstruction is common and more prevalent than chronic airflow obstruction worldwide. Small airways obstruction shows the same risk factors as chronic airflow obstruction. However, further research is required to investigate whether small airways obstruction is also associated with respiratory symptoms and lung function decline.National Heart and Lung Institute and Wellcome Trust. Supported by Wellcome Trust grant 085790/Z/08/Z for the BOLD studyinfo:eu-repo/semantics/publishedVersio

Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990-2019 : a systematic analysis from the Global Burden of Disease Study 2019

Background: Ending the global tobacco epidemic is a defining challenge in global health. Timely and comprehensive estimates of the prevalence of smoking tobacco use and attributable disease burden are needed to guide tobacco control efforts nationally and globally. Methods: We estimated the prevalence of smoking tobacco use and attributable disease burden for 204 countries and territories, by age and sex, from 1990 to 2019 as part of the Global Burden of Diseases, Injuries, and Risk Factors Study. We modelled multiple smoking-related indicators from 3625 nationally representative surveys. We completed systematic reviews and did Bayesian meta-regressions for 36 causally linked health outcomes to estimate non-linear dose-response risk curves for current and former smokers. We used a direct estimation approach to estimate attributable burden, providing more comprehensive estimates of the health effects of smoking than previously available. Findings: Globally in 2019, 1.14 billion (95% uncertainty interval 1.13-1.16) individuals were current smokers, who consumed 7.41 trillion (7.11-7.74) cigarette-equivalents of tobacco in 2019. Although prevalence of smoking had decreased significantly since 1990 among both males (27.5% [26. 5-28.5] reduction) and females (37.7% [35.4-39.9] reduction) aged 15 years and older, population growth has led to a significant increase in the total number of smokers from 0.99 billion (0.98-1.00) in 1990. Globally in 2019, smoking tobacco use accounted for 7.69 million (7.16-8.20) deaths and 200 million (185-214) disability-adjusted life-years, and was the leading risk factor for death among males (20.2% [19.3-21.1] of male deaths). 6.68 million [86.9%] of 7.69 million deaths attributable to smoking tobacco use were among current smokers. Interpretation: In the absence of intervention, the annual toll of 7.69 million deaths and 200 million disability-adjusted life-years attributable to smoking will increase over the coming decades. Substantial progress in reducing the prevalence of smoking tobacco use has been observed in countries from all regions and at all stages of development, but a large implementation gap remains for tobacco control. Countries have a dear and urgent opportunity to pass strong, evidence-based policies to accelerate reductions in the prevalence of smoking and reap massive health benefits for their citizens

Craniectomy for Malignant Cerebral Infarction: Prevalence and Outcomes in US Hospitals

Randomized trials have demonstrated the efficacy of craniectomy for the treatment of malignant cerebral edema following ischemic stroke. We sought to determine the prevalence and outcomes related to this by using a national database.Patient discharges with ischemic stroke as the primary diagnosis undergoing craniectomy were queried from the US Nationwide Inpatient Sample from 1999 to 2008. A subpopulation of patients was identified that underwent thrombolysis. Two primary end points were examined: in-hospital mortality and discharge to home/routine care. To facilitate interpretations, adjusted prevalence was calculated from the overall prevalence and two age-specific logistic regression models. The predictive margin was then generated using a multivariate logistic regression model to estimate the probability of in-hospital mortality after adjustment for admission type, admission source, length of stay, total hospital charges, chronic comorbidities, and medical complications.After excluding 71,996 patients with the diagnosis of intracranial hemorrhage and posterior intracranial circulation occlusion, we identified 4,248,955 adult hospitalizations with ischemic stroke as a primary diagnosis. The estimated rates of hospitalizations in craniectomy per 10,000 hospitalizations with ischemic stroke increased from 3.9 in 1999-2000 to 14.46 in 2007-2008 (p for linear trend<0.001). Patients 60+ years of age had in-hospital mortality of 44% while the 18-59 year old group was found to be 24% (p = 0.14). Outcomes were comparable if recombinant tissue plasminogen activator had been administered.Craniectomy is being increasingly performed for malignant cerebral edema following large territory cerebral ischemia. We suspect that the increase in the annual incidence of DC for malignant cerebral edema is directly related to the expanding collection of evidence in randomized trials that the operation is efficacious when performed in the correct patient population. In hospital mortality is high for all patients undergoing this procedure